Akebia Therapeutics Inc AKBA Q1 2026 Earnings EPS Misses Estimates Slightly Stock Unchanged OneSpan OSPN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains on Profitability Beat SHFS Q3 2024 Earnings Profitability Achieved Despite Limited Disclosure PROV Q1 2026 Earnings EPS Misses Estimates by 336 as Bottom Line Disappoints PEW Q1 2026 Earnings NarrowerThanExpected Loss Surprises Analysts Antero Resources Pulls Back Support Levels in Focus as Natural Gas Weighs Fulton Financial Preferred Shares FULTP Edge Lower Amid Modest Pullback Smart Sand Inc SND Holds Steady Near Support as Energy Sector Shows Mixed Signals MFS Municipal Income Trust CMU Holds Steady Near Support Amid Modest Gains CaliberCos Inc CWD Tests Key Support as Downside Pressure Persists Enliven Therapeutics ELVN Pulls Back 263 as Resistance Holds Support Levels in Focus Oramed Pharmaceuticals ORMP Drops 89 Support Level Under Pressure OneSpan Inc OSPN Slides 109 as Price Approaches Key Support at 1288 Texas Ventures Acquisition III Warrants TVACW Climb 392 Approaching Key Resistance Our Bond Inc OBAI Holds Steady at 045 as Support Level Holds ISBA Q1 2026 Earnings Massive EPS Miss Drives Stock Decline